SG11201502743PA - Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use - Google Patents

Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use

Info

Publication number
SG11201502743PA
SG11201502743PA SG11201502743PA SG11201502743PA SG11201502743PA SG 11201502743P A SG11201502743P A SG 11201502743PA SG 11201502743P A SG11201502743P A SG 11201502743PA SG 11201502743P A SG11201502743P A SG 11201502743PA SG 11201502743P A SG11201502743P A SG 11201502743PA
Authority
SG
Singapore
Prior art keywords
hydroxyapatite
hyaluronic acid
sterile aqueous
aqueous formulation
crosslinked hyaluronic
Prior art date
Application number
SG11201502743PA
Other languages
English (en)
Inventor
Molliard Samuel Gavard
Original Assignee
Anteis Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anteis Sa filed Critical Anteis Sa
Publication of SG11201502743PA publication Critical patent/SG11201502743PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
SG11201502743PA 2012-10-08 2013-09-24 Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use SG11201502743PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1259577 2012-10-08
PCT/EP2013/069874 WO2014056722A2 (fr) 2012-10-08 2013-09-24 Formulation aqueuse stérile injectable à base d'acide hyaluronique réticulé et d'hydroxyapatite pour usage esthétique

Publications (1)

Publication Number Publication Date
SG11201502743PA true SG11201502743PA (en) 2015-05-28

Family

ID=47295066

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201502743PA SG11201502743PA (en) 2012-10-08 2013-09-24 Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use

Country Status (22)

Country Link
US (2) US20150257989A1 (he)
EP (1) EP2903589B1 (he)
JP (1) JP6342906B2 (he)
KR (1) KR101773989B1 (he)
CN (1) CN104703582B (he)
AR (1) AR092933A1 (he)
AU (1) AU2013329751B2 (he)
BR (1) BR112015007772B1 (he)
CA (1) CA2887316C (he)
ES (1) ES2668689T3 (he)
HK (1) HK1210429A1 (he)
IL (1) IL237848B (he)
IN (1) IN2015DN02298A (he)
LT (1) LT2903589T (he)
MX (1) MX360833B (he)
PL (1) PL2903589T3 (he)
RU (1) RU2648450C2 (he)
SG (1) SG11201502743PA (he)
TR (1) TR201807119T4 (he)
TW (1) TWI641393B (he)
WO (1) WO2014056722A2 (he)
ZA (1) ZA201501697B (he)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2885884A1 (fr) * 2012-10-08 2014-04-17 Aptissen S.A. Formulation aqueuse sterile injectable a base d'acide hyaluronique reticule et d'hydroxyapatite pour usage therapeutique
US10463762B2 (en) * 2012-10-08 2019-11-05 Anteis S.A. Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use
TWI716365B (zh) * 2014-11-13 2021-01-21 德商梅茲製藥有限兩合公司 注射型真皮填充劑組合物及其套組、製備方法、與使用
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
FR3036035B1 (fr) * 2015-05-11 2018-10-05 Laboratoires Vivacy Compositions comprenant au moins un polyol et au moins un anesthesique
JP6660469B2 (ja) 2015-11-24 2020-03-11 ビーエムアイ コリア カンパニー リミテッド ヒアルロン酸誘導体およびｄｎａ分画物が含まれているヒアルロン酸注射用組成物およびその利用
FR3044557B1 (fr) * 2015-12-07 2017-12-01 Benedicte Vincente Gavard Molliard Tauzin Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
KR101886413B1 (ko) * 2016-03-16 2018-08-10 주식회사 엘앤씨바이오 히알루론산에 기반한 연조직 충진 조성물의 제조 방법
PL3377126T3 (pl) 2016-07-27 2019-08-30 Marbelle Threads Ltd. Nici usieciowanego kwasu hialuronowego i hydroksyapatytu
CA3035153A1 (en) * 2016-09-07 2018-03-15 Luminera Derm Ltd. Injectable gels comprising cross-linked hyaluronic acid and hydroxyapatite, and methods of manufacturing thereof
IT201700008651A1 (it) * 2017-01-26 2018-07-26 Beauty System Pharma Ltd Acido ialuronico reticolato con agenti reticolanti di tipo naturale o semisintetico
CN107496990A (zh) * 2017-08-15 2017-12-22 广东泰宝医疗器械技术研究院有限公司 一种可注射的抗菌软骨修复水凝胶及其制备方法
WO2019073386A1 (en) * 2017-10-10 2019-04-18 E.N.A. Impeccable Skincare Solutions Ltd MANUFACTURING METHOD AND DERMAL BLEMISHING COMPOSITIONS CONTAINING HYALURONIC ACID AND HYDROXYAPATITE
WO2019182745A1 (en) 2018-03-19 2019-09-26 Bryn Pharma, LLC Epinephrine spray formulations
WO2019197608A1 (en) 2018-04-13 2019-10-17 Merz Pharma Gmbh & Co. Kgaa Dermal filler based on crosslinked hyaluronic acid, calcium phosphate material particles and carboxymethyl cellulose, a process for preparing same and uses thereof
CN108744054A (zh) * 2018-06-15 2018-11-06 北京水元生生物科技有限公司 一种注射型美容整形用面部填充剂组合物凝胶及其制备方法
WO2020095079A1 (fr) * 2018-11-06 2020-05-14 Kylane Laboratoires Sa Composition injectable contenant de l'acide hyaluronique pour des applications au niveau du corps
CN111166686A (zh) * 2018-11-12 2020-05-19 无锡市伙伴日化科技有限公司 一种玻尿酸爽肤水
US20230108822A1 (en) * 2020-02-06 2023-04-06 Merz Pharma Gmbh & Co. Kgaa Injectable composition for skin and soft tissue augmentation
ES2947097A1 (es) * 2022-02-01 2023-08-01 Martinez Miguel Angel Gomariz Metodo cosmetico de rejuvenecimiento de la piel

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537574B1 (en) * 1992-02-11 2003-03-25 Bioform, Inc. Soft tissue augmentation material
DE69331096T2 (de) 1992-02-28 2002-08-14 Cohesion Tech Inc Injektierbare, keramische verbindungen sowie verfahren zur deren herstellung und anwendung
US7842300B2 (en) 2002-07-31 2010-11-30 Dentsply International, Inc. Bone repair putty
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
US20100004700A1 (en) 2008-03-05 2010-01-07 Neville Alleyne Method of treating tissue with a suspenson of tricalcium hydroxyapatite microspheres
CN101596328A (zh) 2008-06-02 2009-12-09 山东省生物药物研究院 一种复合生物材料及其制备方法和应用
FR2938187B1 (fr) * 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
FR2945949B1 (fr) * 2009-05-26 2011-05-13 Anteis Sa Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme.
NZ599527A (en) 2009-11-09 2014-04-30 Spotlight Technology Partners Llc Fragmented hydrogels
US8915043B2 (en) * 2011-05-25 2014-12-23 General Electric Company Bolt connection for a wind tower lattice structure
ITAN20110138A1 (it) * 2011-10-12 2012-01-11 Regenyal Lab S R L Sintesi di un gel iniettabile multifasico a base di acido ialuronico monofasico libero e reticolato e di acido ialuronico bifasico associato con idrossiapatite con inibitore della ialuronidasi microincapsulato.
CA2885884A1 (fr) 2012-10-08 2014-04-17 Aptissen S.A. Formulation aqueuse sterile injectable a base d'acide hyaluronique reticule et d'hydroxyapatite pour usage therapeutique

Also Published As

Publication number Publication date
KR20150064090A (ko) 2015-06-10
IN2015DN02298A (he) 2015-08-21
US20180193232A1 (en) 2018-07-12
ES2668689T3 (es) 2018-05-21
WO2014056722A3 (fr) 2014-07-10
LT2903589T (lt) 2018-06-11
CA2887316A1 (en) 2014-04-17
RU2648450C2 (ru) 2018-03-26
KR101773989B1 (ko) 2017-09-12
WO2014056722A2 (fr) 2014-04-17
ZA201501697B (en) 2016-11-30
US10493006B2 (en) 2019-12-03
TR201807119T4 (tr) 2018-06-21
PL2903589T3 (pl) 2018-08-31
BR112015007772A2 (pt) 2017-07-04
EP2903589A2 (fr) 2015-08-12
CN104703582A (zh) 2015-06-10
HK1210429A1 (en) 2016-04-22
EP2903589B1 (fr) 2018-04-18
IL237848B (he) 2019-07-31
RU2015115974A (ru) 2016-11-27
AR092933A1 (es) 2015-05-06
TW201427708A (zh) 2014-07-16
MX360833B (es) 2018-11-20
AU2013329751A1 (en) 2015-04-16
JP2015536911A (ja) 2015-12-24
CA2887316C (en) 2020-04-21
IL237848A0 (he) 2015-05-31
BR112015007772B1 (pt) 2020-05-05
CN104703582B (zh) 2017-11-24
US20150257989A1 (en) 2015-09-17
MX2015004307A (es) 2015-08-20
AU2013329751B2 (en) 2017-12-21
TWI641393B (zh) 2018-11-21
JP6342906B2 (ja) 2018-06-13

Similar Documents

Publication Publication Date Title
HK1210429A1 (en) Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use
PL2912074T5 (pl) Sterylna kompozycja do wstrzykiwania przez skórę
EP2858697A4 (en) Preventing inadvertent changes in ambulatory medical devices
HK1208350A1 (en) Sterilised composition comprising at least one hyaluronic acid and magnesium ascorbyl phosphate
EP2879593A4 (en) SYSTEMS AND METHODS FOR TISSUE REPAIR
HUE038664T2 (hu) Hialuronsav C6-C18-acilezett származéka, eljárás annak elõállítására, erre épülõ nanomicelláris kompozíció, eljárás annak elõállítására és eljárás stabilizált nanomicelláris kompozíció elõállítására, valamint annak alkalmazása
HRP20190131T1 (hr) Farmaceutske formulacije koje sadrže hondroitin-sulfat i derivate hijaluronske kiseline
EP2858719A4 (en) Systems and methods for tissue treatment
ZA201502988B (en) A stable aqueous composition comprising human insulin or an analogue or derivative thereof
EP2822533A4 (en) BIOMATERIALS FOR THE DISTRIBUTION OF BLOOD EXTRACTS AND USE METHOD THEREFOR
EP3071236A4 (en) Injectable tissue supplement
EP3081232A4 (en) Hyaluronic acid gel composition having sustained release property
HK1210941A1 (en) Modified hyaluronic acid derivatives and use thereof
EP2937088A4 (en) COMPOSITION HAVING TISSUE REPAIR ACTIVITY AND USE THEREOF
HK1205698A1 (en) Chondroitin for use in medicine
PL2938350T3 (pl) Formulacja medyczna do leczenia hipercholesterolemii
EP2832724A4 (en) NIPETIC ACID DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
IL221087A (he) הרכב רוקחות או תזונתי
PT2983691T (pt) Associação sinérgica da alanina-glutamina, o ácido hialurónico e um extrato de aveia e sua utilização em uma composição destinada à cicatrização e o reparo das lesões cutâneas
GB201215502D0 (en) Medical use
AU2012903976A0 (en) Skin Treatment Formulation
EP2999336A4 (en) Indication and technique for the use of cross-linked hyaluronic acid in the management of pain
AU2012903356A0 (en) Improvements in Medical Treatment
GB201214541D0 (en) Skin treatment formulation, and use thereof